Competing‐risks model for prediction of small‐for‐gestational‐age neonate from biophysical and biochemical markers at 11–13 weeks' gestation
I. Papastefanou,D. Wright,A. Syngelaki,K. Souretis,E. Chrysanthopoulou,K. H. Nicolaides
DOI: https://doi.org/10.1002/uog.23523
2020-12-09
Ultrasound in Obstetrics and Gynecology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To develop a new competing risks model for the prediction of small for gestational age (SGA) neonates, based on maternal factors and biophysical and biochemical markers at 11 ‐ 13 weeks' gestation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>This is a prospective observational study in 60,875 women with singleton pregnancies undergoing routine ultrasound examination at 11<sup>+0</sup> ‐ 13<sup>+6</sup> weeks' gestation. All pregnancies had PAPP‐A and PlGF measurements, 59,001 had uterine artery pulsatility index (UtA‐PI) measurements and 58,479 had mean arterial pressure (MAP) measurements; 57,131 cases had complete data for all biomarkers. We used a previously developed competing risks model for the joint distribution of gestational age at delivery (GA) and birth weight Z score (Z), according to maternal demographic characteristics and medical history. The likelihoods of the biophysical markers were developed by fitting folded plane regression models, a technique that has already been used in previous studies for the likelihoods of biochemical markers. The next step was to modify the prior distribution by the likelihood, according to Bayes theorem, to obtain individualized distributions for GA and Z. We used the 57,131 cases with complete data, to assess the discrimination and the calibration of the model for predicting SGA with, without or independently of preeclampsia (PE), by different combinations of maternal factors and biomarkers. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The distribution of biomarkers, conditional to both GA and Z, was best described by folded plane regression models. These continuous two‐dimensional likelihoods update the joint distribution of Z and GA that has resulted from a competing risks approach; this method allows application of user‐defined cut‐offs. The best biophysical predictor of preterm SGA was UtA‐PI and the best biochemical marker was PlGF. The prediction of SGA was consistently better for increasing degree of prematurity, higher severity of smallness, co‐existence of PE and increasing number of biomarkers. The combination of maternal factors with all biomarkers predicted 34.3%, 48.6% and 59.1% of all cases of SGA neonates with birth weight <10th percentile delivered at ≥37, <37 and <32 weeks' gestation, at 10% false positive rate. The respective values for birth weight <3rd percentile were 39.9%, 53.2% and 64.4% and for birth weight <3rd percentile with PE were 46.3%, 66.8% and 80.4%. The new model was well calibrated.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The study has presented a single continuous two‐dimensional model for prediction of SGA for any desired cut‐offs in smallness and gestational age, laying the ground for a personalized antenatal plan for predicting and managing SGA, in the milieu of a new inverted pyramid of prenatal care.</p><p>This article is protected by copyright. All rights reserved.</p></section>
radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics